Investigational drug improves symptoms of Cushing’s disease
Links shared publicly online about this topic.
- 240total visits
Investigational drug improves symptoms of Cushing’s disease
View full resource at endocrinetoday.com
Tags: Disease and Condition, Drug, disease
Most Recently Shared on June 5, 2011 at 5:30 pm By:
Investigational drug improves symptoms of Cushing’s disease http://ow.ly/5asom #endo11
Pasireotide: Experimental drug reduces cortisol levels, improves symptoms in Cushing's disease
cushie.info — “A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted.” View full resource at cushie.info
Most Recently Shared on March 16, 2012 at 12:52 pm By:
MaryO Patient Expert and Active Health Library
Pasireotide: Experimental drug reduces cortisol levels, improves symptoms in Cushing's disease http://t.co/SMWEaB0e
Cushing's Disease Symptoms, Cortisol Levels, Reduced By Experimental Drug
medicalnewstoday.com — “A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results” View full resource at medicalnewstoday.com
Most Recently Shared on March 9, 2012 at 8:05 am By:
Cushing's Disease Symptoms, Cortisol Levels, Reduced By Experimental Drug http://t.co/7fqP5AHm #endocrinology
Medical News: ASCO: Novel Drug Offers Hope in Myelofibrosis - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- An investigational JAK inhibitor significantly improved symptoms for patients with myelofibrosis, an incurable bone marrow disease, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:35 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: Novel Drug Offers Hope in Myelofibrosis - http://t.co/GRicwGj from @medpagetoday #health #medicine
Medical News: Investigational Agent Improves Motility in Parkinson's Patients - in Geriatrics, Parkinson's Disease from MedPage Today
medpagetoday.com — “Droxidopa, an investigational norepinephrine pro-drug, significantly reduced symptoms of neurogenic orthostatic hypotension in Parkinson's disease patients, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on December 16, 2009 at 5:37 pm By:
Investigational Agent Improves Motility in Parkinson's Patients (CME/CE) Droxidopa, an investigational norepinephrine.. http://bit.ly/5DMo0Q
Advertisement
